Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 11:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 222 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Emotional Sensitivity test Clear all

Conditions: SARS-CoV-2 Infection, COVID-19
Interventions: iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test; Device · Diagnostic Test
Lead sponsor: New Day Diagnostics; Network
Eligibility: 2 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 2
States / cities: Anaheim, California • Knoxville, Tennessee

Conditions: Low Vision, Neovascular Age-related Macular Degeneration
Interventions: Vision rehabilitation; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years to 105 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pre-diabetes
Interventions: vitamin D, placebo; Drug
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 18 Years to 90 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Porphyrias
Interventions: Web-based Survey; Other
Lead sponsor: University of South Florida; Other
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Ovarian Cancer
Interventions: Drug Response Predictor® (DRP); Device
Lead sponsor: Allarity Therapeutics; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 7
States / cities: Tampa, Florida • Atlanta, Georgia • Albuquerque, New Mexico + 4 more

Conditions: Behavior, Infant
Interventions: Control, Sensitivity Intervention, Couples' Intervention, Sensitivity and Couples' Intervention; Behavioral
Lead sponsor: Colorado State University; Other
Eligibility: 6 Months and older
Enrollment: 1,005 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2028
U.S. locations: 2
States / cities: Fort Wayne, Indiana • South Bend, Indiana

Conditions: Obesity, Weight Loss
Interventions: Standard behavioral treatment, SBT + technology system (SBT+FIT); Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 21 Years to 55 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Central Visual Impairment, Macular Degeneration
Interventions: Training visual sensitivity, Combination training; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Insulin Sensitivity
Interventions: Continuous Insulin administration during hyperinsulinemic euglycemic clamp test, Pulsatile Insulin administration during hyperinsulinemic euglycemic clamp test; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 50 Years to 75 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Type 2 Diabetes
Interventions: Pioglitazone; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 35 Years to 64 Years
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy Adult
Interventions: Aerobic High Intensity Interval Training; Behavioral
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 18 Years to 50 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Knee Osteoarthritis
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 45 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Multiple Sclerosis
Interventions: BeCare Mobile App; Device
Lead sponsor: BeCare Link LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Myocardial Infarction
Interventions: i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity; Diagnostic Test
Lead sponsor: Abbott Point of Care; Industry
Eligibility: 18 Years and older
Enrollment: 3,697 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 28
States / cities: Chandler, Arizona • San Francisco, California • Stanford, California + 25 more

Conditions: Colorectal Cancer
Interventions: Cologuard, Fecal Immunochemical Test; Diagnostic Test
Lead sponsor: University of California, San Diego; Other
Eligibility: 45 Years to 49 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Visual Acuity
Interventions: senofilcon A, Control; Device
Lead sponsor: Johnson & Johnson Vision Care, Inc.; Industry
Eligibility: 18 Years to 35 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Genetic Disease
Interventions: Whole genome sequencing, BeginNGS test, WES; Genetic
Lead sponsor: Rady Pediatric Genomics & Systems Medicine Institute; Other
Eligibility: 1 Day to 10 Days
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Obesity
Interventions: Oral sugar tolerance test, De novo lipogenesis test, Gluconeogenesis test; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 10 Years to 20 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Misophonia, Emotion Dysregulation, Sensory Processing Disorder, Auditory Over Responsivity, Anxiety Disorder, Sound Sensitivity
Interventions: High Frequency Repetitive Transcranial Magnetic Stimulation (HF rTMS), Sham Repetitive Transcranial Magnetic Stimulation (sham- rTMS), Cognitive Restructuring; Device · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Vasoconstriction, Vasodilation
Interventions: Handgrip Exercise Training, Acetylcholine, Adenosine Triphosphate, Atropine, Phenylephrine, Sodium Nitroprusside; Other · Drug
Lead sponsor: Colorado State University; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer
Interventions: AZD9291; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 603 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2023
U.S. locations: 7
States / cities: Aurora, Colorado • Atlanta, Georgia • Boston, Massachusetts + 3 more

Conditions: Transgender Persons
Interventions: Botnia Clamp, Withdrawal of Gender Affirming Hormone Therapy (GAHT); Drug · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetes
Interventions: Insulin, glucose and staple isotopes; Procedure
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Food Sensitivities, Headache, Backache, Indigestion, Eczema, Acne, Hives and Itching of the Skin
Interventions: NAET Procedures; Procedure
Lead sponsor: Nambudripad's Allergy Research Foundation; Other
Eligibility: 2 Years to 78 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Buena Park, California

Search by objective public record fields.

COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation

Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy

Vitamin D in Minorities With Prediabetes

Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria

Clinical Pre-screening Protocol for Ovarian Cancer

Efficacy of Family Programs for Improving Child and Family Health and Development

Comparison of Weight Loss Programs for Individuals With Severe Obesity

Factors in Learning And Plasticity: Macular Degeneration

Effect of Pulsatile Hormone Administration on Insulin Action

Pharmacogenomics of Thiazolidinediones

Impact of Aerobic Exercise on Pain Modulation in Healthy Adults

Transcranial Direct Current Stimulation in Older Persons With Knee Pain (Knee Pain and tDCS): Randomized Pilot Study

Patient Centered Outcomes Analysis for MS Using a Mobile Application

Abbott i-STAT High Sensitivity Troponin I Study

Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT

Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers

Newborn Genomic Sequencing Pilot Study

Metabolic Pathology of Pediatric NAFLD

Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study

Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training

AZD9291 First Time In Patients Ascending Dose Study

Effect of Gender Affirming Hormone Therapy on Glucose Metabolism

Experimental Study to Validate the Modified Glucose Disposal Test

NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®